Dexmedetomidine in anaesthesia
- 1 August 2005
- journal article
- drugs in-anaesthesia
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 18 (4) , 412-418
Abstract
Purpose of review The development of dexmedetomidine, a potent and highly selective α2-adrenoceptor agonist, has created new interest in the use of α2-adrenoceptor agonists, and has led to its evaluation in various yet non-approved perioperative settings. The current review focuses on the usefulness of dexmedetomidine in anaesthesia practice. Recent findings Recently acquired knowledge and experience with dexmedetomidine in perioperative use will be presented and discussed in the context of known pharmacological properties. Summary Dexmedetomidine offers beneficial pharmacological properties, providing dose-dependent sedation, analgesia, sympatholysis and anxiolysis without relevant respiratory depression. The side-effects are predictable from the pharmacological profile of (2-adrenoceptor agonists. In particular, the unique sedative properties of dexmedetomidine resulted in several interesting applications in anaesthesia practice, promising benefits in the perioperative use of this compound. However, dexmedetomidine was approved for sedation in the intensive care unit in the USA in 1999, and administration in anaesthesia practice remains an ‘off-label’ use. Further studies are needed to establish the role of dexmedetomidine in the perioperative period.Keywords
This publication has 81 references indexed in Scilit:
- Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypesPharmacology & Therapeutics, 2004
- Physiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enoughAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Seven-transmembrane-spanning receptors and heart functionNature, 2002
- Clinical Uses of α2-Adrenergic AgonistsAnesthesiology, 2000
- α2-Adrenoceptor agonists in anaesthesia: a new paradigmCurrent Opinion in Anaesthesiology, 2000
- DexmedetomidineDrugs, 2000
- Gene Substitution/Knockout to Delineate the Role of α2‐Adrenoceptor Subtypes in Mediating Central Effects of Catecholamines and ImidazolinesAnnals of the New York Academy of Sciences, 1999
- Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2.Proceedings of the National Academy of Sciences, 1990
- Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.Proceedings of the National Academy of Sciences, 1988
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987